Barclays Adjusts Price Target on CVS Health to $65 From $63
Wolfe Research Adjusts Price Target on CVS Health to $64 From $70, Keeps Outperform Rating
CVS Health Analyst Ratings
Cantor Fitzgerald Reiterates Neutral on CVS Health, Maintains $58 Price Target
Komo: Maintaining the CVS Health (CVS.US) rating, adjusted from an increase in holdings to an increase in holdings rating, and the target price was adjusted from $101.00 to $86.00.
CVS Health Analyst Ratings
JPMorgan Adjusts Price Target on CVS Health to $86 From $101
CVS Health (CVS) Receives a Hold From Wells Fargo
CVS Health Analyst Ratings
CVS Health Corp: J.P. Morgan cuts target price from $101 to $86
Wolfe Research Lowers CVS Health's Price Target to $64 From $70
Buy Rating Affirmed: CVS Health's Proactive Strategies Counter Medicare Advantage Pressures and Unlock Growth Opportunities
Argus Research Sticks to Its Buy Rating for CVS Health (CVS)
Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), CVS Health (CVS)
CVS Health Analyst Ratings
Argos Consulting: Maintaining the CVS Health (CVS.US) rating, adjusted from a buy rating to a buy rating, and the target price was adjusted from $100.00 to $80.00.
Argus Research Adjusts Price Target on CVS Health to $80 From $100
Wells Fargo cuts target price of CVS Health to $60
TD Cowen downgrades CVS Health's rating and target price
Wells Fargo: Maintaining the CVS Health (CVS.US) rating, adjusted from a wait-and-see shareholding rating to a shareholding wait-and-see rating, and the target price was adjusted from $76.00 to $60.00.